A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Participants with DCIS Following Breast Conserving Therapy

General Information Age Group Adults Status Recruiting Protocol Number NCT03448926 Offered At Inova Schar Cancer Institute 8081 Innovation Park Drive Fairfax, VA 22031A department of Inova Fairfax Hospital Inova Loudoun Hospital 44045 Riverside Pkwy Leesburg, VA 20176 Inova Fair Oaks Medical Campus 3580 Joseph Siewick Drive Fairfax, VA 22033 Inova Alexandria Hospital 4320 Seminary Road Alexandria, VA 22304 Eligibility Information Participant must have histologically confirmed ductal carcinoma in situ (DCIS) in a single breast. (LCIS) or other benign breast disease in addition to DCIS is acceptable. Participant must have the DCISionRT™ Test ordered during routine participant care Participant must be planning to undergo breast conserving surgery Participant must be eligible to receive radiation and/or systemic treatment Participant must be greater than 25 years old Participant must have been diagnosed with DCIS within 120 days of consent Additional eligibility in protocol Ineligibility Information Participant tissue is insufficient to generate DCISionRT test results or required DCISionRT inputs are missing Participant has evidence of invasive breast cancer, including microinvasion, lymph node involvement, or Paget's disease of the nipple or suspicious mammogram findings in the lymph nodes or contralateral breast Participant has been surgically treated with a mastectomy for primary DCIS Participant has prior in situ or invasive breast cancer Additional ineligibility in protocol For more information, go to: https://clinicaltrials.gov/ct2/show/NCT03448926 Contact Information Contact Name Sangeetha Moturi Contact Phone 571-472-0343 Contact Email Send Email